Document Type : Research Paper

Author

Assistant Professor, Department of Biology, Islamic Azad University, Tonekabon Branch of Iran

Abstract

Occurrence Rate Determination of Candidian Denture Stomatitis in Patients of Dentistry Centers and Survey Susceptibility Them to Antifungal Agents
Hashemi Karoei Seyed Masoud1*
Department of Microbiology, tonekabon Branch Islamic Azad University, Iran
Abstract
The presence or entry of Candida yeast to the oral cavity with underlying conditions plays an essential role in the creation Denture stomatitis. Different types of Candida especially C. albicans able to create Denture stomatitis that shows different reacts to antifungal drugs. The aim of this study was determination of Candidian denture stomatitis and sensitive of them to antifungal drugs that was performed with laboratory tests and gel diffusion method. In this research Candida yeast isolated and identified in 20 samples (%46.51) of 43 samples of Denture stomatitis that were 13 cases (65%) C. albicans, 4 cases (20%) C.kerosei, 1 cases (5%) C.tropicalis and 2 cases (10%) other Candida. By comparing the average diameter of growth inhibition zoon of Candida according to kind of antifungal drug by Duncan test it was found that with P v < 0.001 Terbinafine with growth inhibition zoon Equal to 43.15 ± 4.52 and Griseofulvin with growth inhibition zoon Equal to 8.25 ± 6.40 had highest and the lowest effect respectively.
Key word: Occurrence Rate, Candidian Denture Stomatitis, Dentistry Centers, Antifungal Agents

Keywords

Carmen, S.  Michelangelo, P. María, C. Vincenzo E.  Maurizio, B. Lucio, M.  Agostino, G.  Massimo, P. Rosario, S. (2011). Candida-associated denture stomatitis. Med Oral Patol Oral Cir Bucal. 1; 16 (2):e139-43 .
Cruciani, M. & Serpelloni, G. (2008). Management of Candida infections in the adult intensive care unit. Expert Opin Pharmacother 9: 175–191.
Daniluk, T. Tokajuk, G. Stokowska, W. Fiedoruk, K. Ściepuk, M. Zaremba, ML. Roskiewicz, D. Cylwik-Rokicka, D. Kędra, BA. Anielska, I. Górska, M.  Kędra, BR. (2006). Occurrence rate of oral Candida albicans in denture wearer patients. Advances in Medical Sciences · Vol . 51. Suppl 1: 77-80.
Eggimann, P. Garbino, J. & Pittet, D. (2003). Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infection Disease 3: 685–702.
Horn, D. L. Neofytos, D. Anaissie, E. J. Fishman, J. A. Steinbach, W. J. Olyaei, A. J. Marr, K. A. Pfaller, M. A. Chang, C. H. & Webster, K. M. (2009). Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clinical Infection Disease 48: 1695–1703
J. C. O. Sardi, L. Scorzoni, T. Bernardi, A. M. Fusco-Almeida and M. J. S. (2013). Mendes Giannini: Candida species: current epidemiology,pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. Journal of Medical Microbiology. 62: 10–24
  L. T. Mathaba, G. Davies and J. R. Warmington (1995). The genotypic relationship of Candida albicans strains isolated from the oral cavity of patients with denture stomatitis. Journal of Medical Microbiology. Vol. 42: 372-379.
Ortega, M. Marco, F. Soriano, A. Almela, M. Martı´nez, J. A. Lo´ pez, J. Pitart, C. & Mensa, J. (2011). Candida species bloodstream infection: epidemiology and outcome in a single institution from  1991 to 2008. Journal Hospital Infection 77: 157–161.
Pfaller, M. A. Messer, S. A. Hollis, R. J. Boyken, L. Tendolkar, S. Kroeger, J. & Diekema, D. J (2009). Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. J Clinical Microbiology 47: 3185–3190.
Pietruski, JK. Sacha, P. Zaremba, M. Gołębiewska, M. Stokowska, W (1997). Yeast infection in denture stomatitis patients. Part I. Fungal floraassessment. Prot Stom 47: 197-202
Sardi, J. C. Almeida, A. M. & Mendes Giannini, M. J (2011). New antimicrobial therapies used against fungi present in subgingival sites – a brief review. Archive Oral Biology 56: 951–959.
Staib, P. Kretschmar, M. Nichterlein, T. Ko¨ hler, G. & Morschha¨ user, J (2000). Expression of virulence genes in Candida albicans. Advenced Exp Medical Biology 485: 167–176.
Silva, S. Negri, M. Henriques, M. Oliveira, R. Williams, D. W. & Azeredo, J (2011). Adherence and biofilm formation of non- Candida albicans Candida species. Trends Microbiol 19: 241–247.
Janelle, M, H. Sabouraud agar for fungal growth. In: Vijai K G.Maria G T. Laboratory protocols in fungal biology (2013). 2et ed. Springer New York Heidelberg Dordercht London: Springer pp 211-216.
Wayne PA. Zone diameter interpretive standards, corresponding minimal inhibitory concentration (MIC) interpretive breakpoints, and quality control limits for antifungal disk diffusion susceptibility testing of yeasts; Informational supplement CLSI document M44-S2. 2nd ed. Clinical and Laboratory Standards Institute; 2008.
Webb. BC, Thomas. CJ, Willcox. MD, Harty. DW, Knox. KW; 1998. Candida- associated denture stomatitis. Aetiology and management: a review. Part 2. Oral diseases caused by Candida species. Austeralian Dental Jounal 43:160-6.